Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 62 M60 M58 M59 M62 M75 M 254 M Research & development —————— — Operating income 431 M727 M356 M746 M679 M778 M 2.56 B Non-Operating Income, Total -14 M-6 M-32 M18 M-6 M54 M 34 M Interest expense, net of interest capitalized —————— — Non-Operating Income, excl. Interest Expenses 25 M18 M17 M34 M22 M85 M 158 M Unusual income/expense -39 M-24 M-49 M-16 M-28 M-31 M -124 M Pretax income 306 M611 M219 M635 M569 M664 M 2.09 B Equity in earnings —————— — Taxes 103 M131 M199 M46 M105 M126 M 476 M Non-controlling/minority interest -1 M8 M2 M03 M4 M 9 M After tax other income/expense 305 M122 M-2 M127 M234 M-20 M 339 M Net income before discontinued operations 204 M472 M18 M589 M461 M534 M 1.6 B Discontinued operations —————— — Net income 204 M472 M18 M589 M461 M534 M 1.6 B Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 204 M472 M18 M589 M461 M534 M 1.6 B Basic earnings per share (Basic EPS) 0.240.550.02—0.550.64 — Diluted earnings per share (Diluted EPS) 0.240.550.020.690.550.64 1.9 Average basic shares outstanding 866 M857 M849 M853 M837 M836 M — Diluted shares outstanding 866 M857 M850 M853 M839 M838 M — EBITDA 708 M1.01 B641 M1.04 B974 M1.07 B 3.73 B EBIT 431 M727 M356 M746 M679 M778 M 2.56 B Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 277 M284 M285 M290 M295 M296 M 1.17 B